Growth in China's health care sector spurs IPOs and M&A

07/18/2010 | Wall Street Journal, The

Data provider Dealogic reported that 23 drug and health care companies in mainland China and Hong Kong raised $5.37 billion in initial public offerings during the past 10 months, reflecting continued growth in China's health care sector. Analysts also expect more mergers and acquisitions after Charles River Laboratories International paid $1.6 billion for WuXi AppTec in April.

View Full Article in:

Wall Street Journal, The

Published in Brief: